AzTrials
AzTrials

Heat StressNCT05963529

Validity of Humidity Ramp Protocols for Identifying Limits of Survivability in Heat-exposed Persons

A study testing Humidity-ramp protocol, Above-inflection fixed-condition exposure and Below-inflection fixed-condition exposure in people with Heat Stress and Heat Exposure, run by University of Ottawa at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The global populace is at growing risk of heat-related illness due to climate change and accompanying increases in the intensity and regularity of extremely hot temperatures. In heat-exposed persons, heat gain from the environment and metabolism initially exceeds the rate of heat dissipation from the skin. Read more about this study

Who is it for?
Ages 18 to 85 yearsHealthy volunteers can take part
What is being tested?
Humidity-ramp protocol, Above-inflection fixed-condition exposure and Below-inflection fixed-condition exposure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
12 participants
Where
1 siteCanada
Study dates
14 Jul 2023to 24 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Male or female adults.
  • Aged 18-85 years.
  • Non-smoking.
  • English or French speaking.
  • Ability to provide informed consent.

Who cannot join

  • Physical restriction (e.g., due to disease: intermittent claudication, renal impairment, active proliferative retinopathy, unstable cardiac or pulmonary disease, disabling stroke, severe arthritis, etc.).
  • Use of or changes in medication judged by the patient or investigators to make participation in this study inadvisable (e.g., medications increasing risk of heat-related illness; beta blockers, anticholinergics, etc.)

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • University of Ottawa

    Ottawa, Ontario, K1N6N5

Other trials in Canada

About this study

Official title: Evaluating the Validity of a Rapid Humidity Ramp Protocol for Identifying the Upper Environmental Limits of Thermal Compensation in Humans

The global populace is at growing risk of heat-related illness due to climate change and accompanying increases in the intensity and regularity of extremely hot temperatures. In heat-exposed persons, heat gain from the environment and metabolism initially exceeds the rate of heat dissipation from the skin. Heat is stored in the body, causing core and skin temperatures to rise, which in turn triggers autonomically mediated elevations in cutaneous blood flow and sweating to facilitate heat loss. If conditions are compensable, heat loss increases until it balances total heat gain. At this point, the rate of heat storage falls to zero (i.e., heat balance is achieved) and body temperature stabilizes, albeit at a level elevated from thermoneutral conditions. If, however, the maximal achievable rate of heat dissipation is insufficient to offset heat gain, conditions are uncompensable, and prolonged exposure will cause a continual rise in core temperature that can compromise health if left unchecked. The environmental limits of compensability (i.e., the temperatures/humidities above which heat balance can not be maintained) are therefore an important determinant of survival during prolonged heat exposure. Evaluating this limit and how it can be modified (e.g., by behavior or individual factors like age or sex) is an increasingly important and active field of study.

Contemporary evaluations of the environmental limits of compensability utilize "ramping protocols" in which participants are exposed to increasing levels of temperature or humidity (in 5-10 min stages) while core temperature is monitored. It is generally observed that core temperature is relatively stable (or rises slightly) in the early stages of exposure but undergoes an abrupt and rapid increase as heat stress becomes more severe. The conditions (e.g., wet-bulb temperature or wet-bulb globe temperature) at this "inflection point" are taken as the limits of compensability. That is, it is assumed that inflection corresponds to the demarcation point, below which core temperature would remain stable for prolonged periods (theoretically indefinitely if hydration is maintained) but above which heat loss is insufficient to offset heat gain, causing core temperature to rise continuously. Despite the increasing use of these protocols, no study has clearly demonstrated their validity for identifying the environmental limits of compensability. The goal of this project is therefore to assess the validity of ramping protocols for determining the ambient conditions above which thermal compensation is not possible.

Enrolled participants will complete four experimental trials in a climate-controlled chamber: one ramping protocol followed by three randomized fixed-condition exposures. In the ramping protocol, participants will rest in 42°C with 28% relative humidity (RH) for 70 min, after which RH will be increased 3% every 10 min until 70% RH is achieved. The core (esophageal) temperature inflection point will be determined. For the fixed-condition exposures, participants will rest in i) 42°C with RH ~5% below their individual inflection point (below-inflection condition), ii) 42°C with RH ~5% above their individual inflection point (above-inflection condition), and iii) 26°C with 45% RH (control condition). Comparing the rate of change in esophageal temperature between each fixed-condition exposure will provide important insight into the validity of ramping protocols for identifying the limits of compensability.

Being tested
Humidity-ramp protocol, Above-inflection fixed-condition exposure, Below-inflection fixed-condition exposure, Control fixed-condition exposure
Keywords
Heat wave, Hot weather, Heat strain, Cardiovascular strain, Environmental limits for compensability, Extreme heat events, Heat survivability
Medical subject headings
Heat Stress Disorders, Body Temperature Changes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Humidity-ramp protocolOther

    Participants are exposed to 42°C and 28% relative humidity for 70 minutes. Thereafter, humidity is increased 3% until an ambient humidity of 70% is achieved. The humidity at which esophageal temperature (and rectal temperature and heart rate) inflect is subsequently determined.

  • Above-inflection fixed-condition exposureOther

    After a 1 hour equilibrium at 42°C and 28% relative humidity, humidity will be increased 3% every 10 min until it is ~5% higher than the participants' individual esophageal temperature inflection point identified in the humidity ramp protocol. These conditions will be held constant for the remainder of the 9-hour exposure period (starting from the beginning of equilibrium). Tap water will be provided at regular intervals to limit dehydration.

  • Below-inflection fixed-condition exposureOther

    After a 1 hour equilibrium at 42°C and 28% relative humidity, humidity will be increased 3% every 10 min until it is ~5% lower than the participants' individual esophageal temperature inflection point identified in the humidity ramp protocol. These conditions will be held constant for the remainder of the 9-hour exposure period (starting from the beginning of equilibrium). Tap water will be provided at regular intervals to limit dehydration.

  • Control fixed-condition exposureOther

    Participants are exposed for 9-hours to 28°C with 35% relative humidity. Participant will be allowed to drink tap water ad libitum.

Study groups in NCT05963529
Study groupRoleWhat they receive
Humidity-ramp protocolOtherHealthy male and female volunteers. Participants will complete all exposures. The humidity-ramp protocol will necessarily be performed first. The order of the fixed-condition exposures will be randomized.
Receives: Other: Humidity-ramp protocol
Above-inflection fixed-condition exposureExperimentalHealthy male and female volunteers. Participants will complete all exposures. The humidity-ramp protocol will necessarily be performed first. The order of the fixed-condition exposures will be randomized.
Receives: Other: Above-inflection fixed-condition exposure
Below-inflection fixed-condition exposureExperimentalHealthy male and female volunteers. Participants will complete all exposures. The humidity-ramp protocol will necessarily be performed first. The order of the fixed-condition exposures will be randomized.
Receives: Other: Below-inflection fixed-condition exposure
Control fixed-condition exposureActive comparatorHealthy male and female volunteers. Participants will complete all exposures. The humidity-ramp protocol will necessarily be performed first. The order of the fixed-condition exposures will be randomized.
Receives: Other: Control fixed-condition exposure

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Esophageal temperature rate of change

    Rate of change of esophageal temperature measured over the final 2-hours of heat exposure

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  2. Predicted time until 40.2°C esophageal temperature

    Estimated time for esophageal temperature to reach 40.2°C, a commonly-cited criteria for severe heat-illness (e.g., heat stroke), calculated from the end-exposure esophageal temperature and its rate of change (assuming this rate of change is sustained)

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  3. Rectal temperature rate of change

    Rate of change of rectal temperature measured over the final 2-hours of heat exposure

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  4. Predicted time until 40.2°C rectal temperature

    Estimated time for rectal temperature to reach 40.2°C, a commonly-cited criteria for

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

Secondary outcomes (10)
  1. Number of participants unable to finish fixed-condition heat exposure

    Number of participants who could not complete each fixed-condition heat exposure due to participant withdrawal or achieving a core temperature of 39.5°C

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  2. Mean skin temperature rate of change

    Rate of change of skin temperature measured over the final 2-hours of heat exposure

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  3. Heart rate rate of change

    Rate of change of heart rate measured over the final 2-hours of heat exposure

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  4. Esophageal temperature

    Esophageal temperature at the end of the fixed-condition exposures

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  5. Rectal temperature

    Rectal temperature at the end of the fixed-condition exposures

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  6. Mean skin temperature

    Mean skin temperature at the end of the fixed-condition exposures

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  7. Heart rate

    Heart rate at the end of the fixed-condition exposures

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  8. Thermal sensation

    Self-reported thermal sensation at the end of the fixed-condition exposures using and 8-point scale ranging from neutral (0) to extremely hot (8).

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  9. Sweat rate

    Sweat rate at the end of the fixed-condition exposures (calculated via change in body weight)

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

  10. Net fluid loss

    Net fluid loss estimated as the percentage change in body mass over the fixed-condition exposures.

    Measured: End of fixed-condition heat exposure (hour 9 or termination)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jul 2023
  2. Study start14 Jul 2023
  3. Primary completion24 Sep 2023
  4. Study completion24 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
Each participant will complete four trial conditions including one humidity-ramp protocol and three fixed-condition exposures. The humidity ramp protocol will always be completed first. Ambient temperature will remain constant at 42°C. After a 1-hour equilibrium period, relative humidity will be increased by 3% in 10-min increments, from 28% to 70%. The inflection point for core (esophageal) temperature will be subsequently determined. On three separate days following the humidity ramp protocol, participants will complete three fixed-condition exposures in random order: 1) 42°C with relative humidity \>5% below the estimate compensability limit (below-threshold condition); 2) 42°C with relative humidity \>5% above the estimated compensability limit (above-threshold condition) and 3) 28°C with 35% relative humidity (control condition). Exposure will be terminated early if core temperature exceeds 39.2°C or if the participant requests to withdraw.
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
12 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05963529
Sponsor's protocol ID
uORamp
Status last verified
Nov 2023
First submitted
13 Jul 2023
Last updated
29 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified participant data will be made available upon reasonable request and signed access agreement.

Questions about this trial

What is this clinical trial studying?

A study testing Humidity-ramp protocol, Above-inflection fixed-condition exposure and Below-inflection fixed-condition exposure in people with Heat Stress and Heat Exposure, run by University of Ottawa at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Esophageal temperature rate of change (time frame: End of fixed-condition heat exposure (hour 9 or termination)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in